ArticleLife (Basel, Switzerland)2026

Enhancing Hemophilia Care: Real-World Outcomes Following Switching to Extended Half-Life Factor VIII in Greece-The TOOL Study.

Helen Pergantou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.